Patents by Inventor Indranil Sinha

Indranil Sinha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOPRINTER DEVICES, SYSTEMS AND METHODS FOR PRINTING SOFT GELS FOR THE TREATMENT OF MUSCULOSKELETAL AND SKIN DISORDERS
    Publication number: 20200123485
    Abstract: Disclosed are devices, systems and methods that utilize bioprinters to form scaffold structures in situ to facilitate treatment of the musculoskeletal or skin disorders in patients. A method for treating a musculoskeletal disorder of a patient includes positioning a bioprinter at a situs of the musculoskeletal disorder, or a situs of a skin injury, in the patient. The method includes extruding a hydrogel formulation from the bioprinter into the situs. The method includes curing the hydrogel formulation in the situs. The hydrogel formulation has a composition effective to generate, upon the curing, a scaffold structure in the situs to facilitate muscle hypertrophy, or skin wound healing, in the situs.
    Type: Application
    Filed: October 21, 2019
    Publication date: April 23, 2020
    Inventors: Ali Tamayol, Azadeh Mostafavi, Carina Russell, Tyrell Williams, Indranil Sinha, Jacob Quint
  • IREN PROTEIN, ITS PREPARATION AND USE
    Publication number: 20090075889
    Abstract: There are provided DNA sequences encoding TRAF binding proteins, proteins encoded thereby, and their use in the treatment or prevention of pathological conditions associated with NF-?B induction, or an activity mediated by a TRAF.
    Type: Application
    Filed: September 9, 2008
    Publication date: March 19, 2009
    Applicant: Yeda Research and Development Co., Ltd.
    Inventors: David WALLACH, Nikolay Malinin, Indranil Sinha, Stefan Leu
  • IREN protein, its preparation and use
    Patent number: 7429648
    Abstract: There are provided DNA sequences encoding TRAF binding proteins, proteins encoded thereby, and their use in the treatment or prevention of pathological conditions associated with NF-?B induction, or an activity mediated by a TRAF.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: September 30, 2008
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: David Wallach, Nikolay Malinin, Indranil Sinha, Stefan Leu